Cyclin-dependent kinase 10

From WikiMD's Wellness Encyclopedia

Cyclin-dependent kinase 10[edit | edit source]

Cyclin-dependent kinase 10 (CDK10) is a member of the cyclin-dependent kinase family, which are serine/threonine protein kinases involved in the regulation of the cell cycle. CDK10 is known to play a role in cell cycle progression, particularly in the transition from the G2 phase to the M phase.

Structure[edit | edit source]

CDK10, like other cyclin-dependent kinases, requires association with a cyclin partner to be active. The specific cyclin partner for CDK10 is cyclin M (also known as FAM58A). The CDK10-cyclin M complex is crucial for its kinase activity.

Function[edit | edit source]

CDK10 is involved in the regulation of the cell cycle. It has been shown to phosphorylate and regulate various substrates involved in cell cycle progression. CDK10 is particularly important for the G2/M transition, where it helps prepare the cell for mitosis.

Role in Cancer[edit | edit source]

CDK10 has been implicated in various cancers. Alterations in CDK10 expression or function can lead to uncontrolled cell proliferation, a hallmark of cancer. Studies have shown that CDK10 may act as a tumor suppressor, and its downregulation is associated with poor prognosis in certain types of cancer.

Clinical Significance[edit | edit source]

Given its role in cell cycle regulation and cancer, CDK10 is a potential target for cancer therapy. Inhibitors of CDK10 are being investigated for their therapeutic potential in treating cancers where CDK10 is dysregulated.

Research[edit | edit source]

Ongoing research is focused on understanding the detailed mechanisms by which CDK10 regulates the cell cycle and its interactions with other proteins. There is also interest in developing specific inhibitors that can modulate CDK10 activity for therapeutic purposes.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Contributors: Prab R. Tumpati, MD